Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Rheumatoid Arthritis

Overview

Spherix’s coverage of the rheumatoid arthritis segment focuses on tracking brand usage and changes in the treatment paradigm with increasing interest in alternate mechanisms of action in the US and the EU5. We also provide detailed insights in patient characteristics that influence treatment switching decisions.

Services Available

Trending market evolution

  • Rheumatoid Arthritis (US)

  • Rheumatoid Arthritis (EU)

Service Info

RealTime Dynamix™ is an independent service providing strategic guidance through quarterly or semiannual reports, which include market trending and a fresh infusion of event-driven and variable content with each wave. The reports provide an unbiased view of the competitive landscape within rapidly evolving specialty markets, fueled by robust HCP primary research and our in-house team of experts.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

US: quarterly report (n=100-200 respondents)

EU5: semiannual report (n=250 respondents)

Canada: semiannual report (n=50 respondents)

Exploring the patient journey

  • Biologic/Small Molecule Switching in RA (US)

  • Biologic/Small Molecule Switching in RA (EU)

Service Info

RealWorld Dynamix™ is an independent, data-driven service unveiling real patient management patterns through rigorous analysis of large-scale patient chart audits. Insights reveal the “why” behind treatment decisions, include year over year trending to quantify key aspects of market evolution, and integrate specialists’ attitudinal & demographic data to highlight differences between stated and actual treatment patterns.

Report Methodology: Insights are based on patient level data gathered through collaboration with specialty physicians who provide details on clinical and non-clinical patient demographics, along with their rationale for treatment choices.

Sample Size and Frequency

US: annual patient chart audit (n=1,000 charts, n=200 physicians)

EU5: annual patient chart audit (n=1,250 charts, n=250 physicians)

gauging impact of disruptive events

  • Multi Specialty Impact of COVID 19 Rheumatology (US)

  • Rheumatology Biosimilars Today and Tomorrow (US)

  • Fellows and Residents (US)

Service Info

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Learn more about our services

HOW CAN WE PARTNER TOGETHER?

Get more information on Rheumatoid Arthritis Coverage